Citadel Advisors’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5903 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6014 |
|
|
2022
Q4 | – | Sell |
-533
| Closed | -$9K | – | 6141 |
|
|
2022
Q3 | $9K | Buy |
+533
| New | +$9K | ﹤0.01% | 5655 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6129 |
|
|
2022
Q1 | – | Sell |
-4,657
| Closed | -$160K | – | 6463 |
|
|
2021
Q4 | $160K | Buy |
4,657
+988
| +27% | +$33.9K | ﹤0.01% | 5629 |
|
|
2021
Q3 | $225K | Sell |
3,669
-846
| -19% | -$51.9K | ﹤0.01% | 5306 |
|
|
2021
Q2 | $352K | Buy |
4,515
+3,804
| +535% | +$297K | ﹤0.01% | 5059 |
|
|
2021
Q1 | $40K | Buy |
+711
| New | +$40K | ﹤0.01% | 6134 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5135 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4755 |
|
|
2019
Q4 | – | Sell |
-11,720
| Closed | -$2.84M | – | 4694 |
|
|
2019
Q3 | $2.84M | Sell |
11,720
-3,202
| -21% | -$776K | ﹤0.01% | 2088 |
|
|
2019
Q2 | $3.42M | Buy |
+14,922
| New | +$3.42M | ﹤0.01% | 1961 |
|